UK biotech Scancell has reported data from a phase 2 trial of its off-the-shelf DNA plasmid vaccine for melanoma that it says backs a swift move to a larger, registrational study. The SCOPE trial of ...
National AI usage among businesses is 9.2%, with a projected increase to 11.6% in six months. Utah leads state AI business adoption at 15.7%%; Delaware's projected rate is highest at 19.1%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback